✦ LIBER ✦

Peginterferon alfa-2B and lamivudine combination therapy compared with peginterferon alfa-2B for chronic hbeag-positive hepatitis B: A randomized controlled trial in 307 patients

Book ID: 118689377
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 145 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1053/s0270-9139(03)81796-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised clinical trial: efficacy of p

Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance

✍ J. Sun; J.-L. Hou; Q. Xie; X.-H. Li; J.-M. Zhang; Y.-M. Wang; H. Wang; J.-Y. Lai 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

HBeAg-Negative Chronic Hepatitis B: Cost

HBeAg-Negative Chronic Hepatitis B: Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine in Taiwan

✍ David L. Veenstra; Sean D. Sullivan; Ming-Yang Lai; Chuan-Mo Lee; Chia-Ming Tsai 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

HBeAg and hepatitis B virus DNA as outco

HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B

✍ Michael W. Fried; Teerha Piratvisuth; George K. K. Lau; Patrick Marcellin; Wan-C 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 2 views

The aims of this study were to evaluate the usefulness of quantitative hepatitis B e antigen (HBeAg) values for predicting HBeAg seroconversion in patients treated with peginterferon alfa-2a and to assess the dynamic changes in quantitative HBeAg during therapy, compared with conventional measures o

Pharmacodynamics of peginterferon alfa-2

Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study

✍ R. BRUNO; P. SACCHI; C. SCAGNOLARI; F. TORRIANI; L. MAIOCCHI; S. PATRUNO; F. BEL 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

Lamivudine/pegylated interferon alfa-2b

Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B

✍ Themistoklis Vassiliadis; Konstantinos Tziomalos; Kalliopi Patsiaoura; Thomas Za 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

423 A randomized trial of peginteferon a

423 A randomized trial of peginteferon alfa-2B and lamivudine combination treatment versus lamivudine monotherapy in Chinese patients with HBEAG-positive chronic hepatitis B

✍ H.L.Y. Chan; N.W.Y. Leung; A.Y. Hui; C.T. Liew; A.M.L. Chim; F.K.L. Chan; L.C.T. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 82 KB